Bridging the gap between efficacy trials and model-based impact evaluation for new tuberculosis vaccines

Area of Science:

• Epidemiology
• Infectious Disease Modeling
• Vaccinology

Background:

• Tuberculosis (TB) transmission dynamics are complex, making it challenging to interpret reduced epidemiological risk from preventive interventions.
• Clinical trials for vaccine efficacy often yield protection readouts that can correspond to multiple underlying dynamical mechanisms, an issue frequently overlooked.
• Current model-based evaluations of vaccine impact may not fully capture the mechanistic basis of protection.

Purpose of the Study:

• To address the limitation in interpreting TB vaccine efficacy trial data.
• To propose a novel methodology for analyzing efficacy trials to disentangle mechanisms of vaccine action.
• To enhance the mechanistic interpretation of TB vaccine data for improved vaccine development.

Main Methods:

• Development of a methodology combining compartmental models and stochastic simulations.
• Analysis of TB vaccine efficacy trial data using the proposed simulation-based approach.
• Conditioning the analysis on trial design, size, and duration to refine mechanistic insights.

Main Results:

• The proposed methodology successfully disentangles various possible mechanisms of action for vaccine protection against TB.
• The approach provides a deeper interpretation of data from TB vaccine efficacy trials.
• Results are conditioned on specific trial parameters, offering context-specific mechanistic understanding.

Conclusions:

• The developed methodology offers a robust framework for interpreting TB vaccine efficacy trial outcomes.
• This approach enhances the link between clinical trial data and transmission models.
• Provides explicit recommendations for vaccine developers to better understand vaccine mechanisms.